EUVIMEDEUVIMED entdecken
Crossref

Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila

Pragati, Surajit Sarkar

Brain Research · 2025

DOI: 10.1016/j.brainres.2024.149347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Pragati und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi 110 021, India. Hauptthemen laut MEDLINE: tau Proteins, Insulin, Heterochromatin, Tauopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tauopathies are a group of neurodegenerative diseases characterized by the accumulation of paired helical filaments (PHFs)/or neurofibrillary tangles (NFTs) in neuronal/glial cells. Besides hyperphosphorylation of tau protein, aberrant heterochromatin loss and translation dysfunction have emerged as other important aspects contributing to the disease pathogenesis. We have recently reported that tissue-specific downregulation of insulin signaling or its growth-promoting downstream sub-branch effectively reinstates the tau-mediated overactivated insulin pathway, and restricts pathogenic tau hyperphosphorylation and aggregate formation. We next investigated if the downregulation of the insulin pathway or its growth-promoting downstream sub-branch makes any impact on tau-mediated aberrant heterochromatin loss and translation dysfunction. For the first time, we demonstrate that tissue-specific downregulation of insulin signaling or its growth-promoting branch effectively restricts the pathogenic tau-induced heterochromatin loss. We further report that expression of human tau in Drosophila causes induction of the mTOR/4EBP/S6K pathway and energy disbalance which gets effectively balanced upon downregulation of insulin signaling. Our findings establish an imperative role of insulin signaling in effectively mitigating various aspects of tau etiology in Drosophila ranging from hyperphosphorylation, chromatin relaxation, and translational upsurge. Our findings could be beneficial in establishing novel therapeutic options against tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsInsulinHeterochromatinTauopathiesAnimalsTOR Serine-Threonine KinasesHumansSignal TransductionDown-RegulationDrosophila ProteinsDrosophilaRibosomal Protein S6 KinasesDrosophila melanogasterAnimals, Genetically ModifiedPhosphorylationDisease Models, Animal

Stichwörter der Autor:innen

ChromatinInsulin signalingTauopathiesTranscriptionmTOR/4EBP/S6K pathway

Substanzen

TOR Serine-Threonine Kinasestau ProteinsInsulinHeterochromatinDrosophila ProteinsRibosomal Protein S6 Kinases

Autor:innen und Institutionen

  • Department of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi 110 021, India.
  • Department of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi 110 021, India. Electronic address: sarkar@south.du.ac.in.

Zitieren

APA

Pragati, & Sarkar, S. (2025). Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila. Brain Research. https://doi.org/10.1016/j.brainres.2024.149347

Vancouver

Pragati, Sarkar S. Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila. Brain Research. 2025. doi:10.1016/j.brainres.2024.149347

BibTeX
@article{Pragati2025,
  author = {Pragati and Sarkar, Surajit},
  title = {Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2024.149347}
}
Kostenlos starten →